FX has gone on to obtain key 510k approvals to further enhance the already comprehensive line of products focused exclusively on shoulder arthroplasty to include:

32mm glenospheres and humeral cups; stability humeral cups; glenoid baseplates with a central screw (with 7 different screw size options); and, the first-to-market
Titanium Nitride (TiN) coated humeral heads and glenospheres as an alternate bearing surface; Easytech Stemless Anatomical—the first-and-only primary stemless with
peripheral fixation; and, most recently, FX Shoulder USA became the only company to successfully complete enrollment of a stemless reversed IDE study (G180100) in the US.
With an eye toward the future, FX will now continue to grow as a global leader in shoulder arthroplasty. One global brand with one global team of shoulder specialists.
FX will emerge as a leading innovator in our market segment and continue to provide best-in-market options tailor-made with the goal of providing improved and
reproducible patient outcomes.
FX will have a Global Headquarters based in Viriat, France and a US Headquarters in Dallas, TX.

PRCT II - Proximal Humerus Fracture Plate